LANTERN PHARMA INC

Class 042: Software as a service (SaaS) services featuring online non-downloadable bioinformatics and computational biology software for multi-omic data analysis, biomarker analytics, genomic and molecular alteration analysis, drug-response correlation analysis, survival analysis, pathway enrichment analysis, and cross-cohort biological data comparison in the fields of oncology research, drug discovery, precision medicine, clinical research, and biomedical research.

Class 042: Software as a service (SaaS) services featuring online non-downloadable artificial intelligence software for multi-agent scientific workflow automation, computational research task orchestration, biomedical data analysis, scientific literature and database analysis, report generation, and audit logging in the fields of oncology research, drug discovery, precision medicine, biomarker analysis, clinical trial design, and biomedical research

Class 041: Providing online non-downloadable publications, namely, articles, reports, white papers, and newsletters, in the fields of artificial intelligence, systems biology, drug discovery, pharmaceutical research, cancer research, and research relating to other diseases and disorders; educational services, namely, providing webinars in the foregoing fields.; Class 042: Scientific research and development in the field of pharmaceuticals; pharmaceutical research and development; medical and scientific research in the field of cancer; medical and scientific research in the fields of infectious diseases, metabolic and endocrine diseases, autoimmune and inflammatory diseases, neurological diseases, and cardiovascular diseases; drug discovery services; bioinformatics services; providing medical and scientific research information in the fields of pharmaceuticals, drug discovery, artificial intelligence, and systems biology; providing temporary use of non-downloadable software using artificial intelligence and systems biology for analyzing biomedical data to identify therapeutic targets, generate drug candidates, and predict drug efficacy and toxicity; providing a website featuring temporary use of non-downloadable software for the foregoing.; Class 044: Providing a website featuring medical information in the field of cancer; providing a website featuring medical information in the field of diseases and medical conditions other than cancer.

Class 042: Providing temporary use of a non-downloadable artificial intelligence software platform for scientific and biomedical research; providing an online software-as-a-service (SaaS) platform featuring artificial intelligence and machine-learning tools for analyzing biological, genomic, proteomic, clinical, and pharmacological data; scientific research services using artificial intelligence in the field of oncology and rare diseases; providing computational models and simulations for identifying, evaluating, and prioritizing therapeutic targets, drug candidates, and combination therapies; providing artificial intelligence-driven tools for hypothesis generation, in silico experimentation, and data-driven scientific discovery; providing platforms for designing, modeling, and optimizing clinical trial concepts and research protocols for investigational therapies; providing software for predictive analytics, biomarker discovery, drug response modeling, and validation of scientific hypotheses; providing scientific data analysis, visualization, and interpretation services using artificial intelligence; providing online tools for accelerating biomedical research and therapeutic development through computational insight; Class 044: Providing medical and scientific research information in the field of oncology and rare diseases; providing information and analysis relating to biomedical research and drug discovery, not for the purpose of diagnosis or treatment.

Class 042: Software as a service (SaaS) services featuring non-downloadable software that uses artificial-intelligence algorithms to analyze molecular, pharmacokinetic, and clinical data and to generate estimates of blood-brain barrier permeability for drug-discovery, research, and medical-diagnostic purposes; Providing an online biological information service, namely, analysis and interpretation of blood-brain barrier permeability data to assist researchers and pharmaceutical developers in compound selection for scientific research purposes; Class 044: Providing an online biological medical information service featuring analysis and interpretation of blood-brain barrier permeability data to assist physicians, researchers, and pharmaceutical developers in medical treatment planning and compound selection for medical treatment purposes

Pharmaceutical preparations, namely, medications used in chemotherapeutic regimens for the treatment of cancer; pharmaceutical preparations for the treatment of cancer

Drug discovery services; pharmaceutical research and development services in the field of oncology; pharmaceutical drug discovery services in the field of oncology; scientific and medical research and development for pharmaceuticals, pharmaceutical preparations and substances in the field of oncology

drug discovery services; pharmaceutical research and development services in the field of oncology; pharmaceutical drug discovery services in the field of oncology; scientific and medical research and development for pharmaceuticals, pharmaceutical preparations and substances in the field of oncology

"PHARMA"; drug discovery services; pharmaceutical research and development services in the field of oncology; pharmaceutical drug discovery services in the field of oncology; scientific and medical research and development for pharmaceuticals, pharmaceutical preparations and substances in the field of oncology

drug discovery services; pharmaceutical research and development services in the field of oncology; pharmaceutical drug discovery services in the field of oncology; scientific and medical research and development for pharmaceuticals, pharmaceutical preparations and substances in the field of oncology